ストックスクリーナーアプリを入手
18.70
1.42%
-0.27
アフターアワーズ：
19.07
0.37
+1.98%
前日終値:
$18.97
開ける：
$18.82
24時間の取引高:
327.21K
Relative Volume:
0.91
時価総額：
$130.02M
収益：
-
当期純損益:
$-112.46M
株価収益率:
-11.40
EPS:
-1.64
ネットキャッシュフロー:
$-99.89M
1週間 パフォーマンス:
-22.44%
1か月 パフォーマンス:
-44.67%
6か月 パフォーマンス:
+74.60%
1年 パフォーマンス:
+12.10%
1日の値動き範囲:
$18.39
$19.95
1週間の範囲:
$18.39
$24.50
52週間の値動き範囲:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
VOR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
18.70 | 130.02M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-15 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | アップグレード | Stifel | Hold → Buy |
| 2025-06-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 開始されました | Wedbush | Outperform |
| 2022-04-27 | 開始されました | Goldman | Neutral |
| 2021-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2021-12-03 | 開始されました | Robert W. Baird | Outperform |
| 2021-12-02 | 開始されました | Oppenheimer | Outperform |
| 2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-03-25 | 開始されました | B. Riley Securities | Buy |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-03-03 | 開始されました | Evercore ISI | Outperform |
| 2021-03-02 | 開始されました | Goldman | Sell |
| 2021-03-02 | 開始されました | Stifel | Buy |
すべてを表示
Vor Biopharma Inc (VOR) 最新ニュース
Can a trend reversal in Vor Biopharma Inc. lead to recovery2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
How institutional ownership impacts Vor Biopharma Inc. stockQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Vor Bio (NASDAQ: VOR) joins TD Cowen, Evercore chats Nov. 12 and Dec. 2; webcasts - Stock Titan
Why Vor Biopharma Inc. stock could benefit from AI revolution2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Gap Down & Free Long-Term Investment Growth Plans - newser.com
Using Python tools to backtest Vor Biopharma Inc. strategies2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Will Vor Biopharma Inc. stock gain from government policies2025 Pullback Review & AI Powered Market Trend Analysis - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.Wall Street Watch & Low Risk Entry Point Guides - newser.com
Forecasting Vor Biopharma Inc. price range with options data2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Can Vor Biopharma Inc. stock beat analyst upgradesEarnings Beat & Free Weekly Watchlist of Top Performers - newser.com
Pattern recognition hints at Vor Biopharma Inc. upside2025 Top Decliners & Consistent Return Investment Signals - newser.com
Vor Biopharma Inc. stock chart pattern explainedTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Technical signs of recovery in Vor Biopharma Inc.Weekly Risk Report & Safe Entry Momentum Tips - newser.com
Vor Biopharma Inc. stock retracement – recovery analysisWeekly Market Outlook & Accurate Technical Buy Alerts - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Is Vor Biopharma Inc. stock a buy before product launches2025 Earnings Impact & Safe Investment Capital Preservation Plans - fcp.pa.gov.br
Combining price and volume data for Vor Biopharma Inc.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsMarket Trend Review & Real-Time Market Sentiment Reports - newser.com
Is Vor Biopharma Inc. stock a top pick in earnings seasonForecast Cut & Reliable Price Action Trade Plans - fcp.pa.gov.br
Using data models to predict Vor Biopharma Inc. stock movementMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
Vor Biopharma Inc. stock volume spike explainedWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Vor Biopharma Appoints New Chief Medical Officer - MSN
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - The Globe and Mail
Vor Biopharma Inc (VOR) 財務データ
収益
当期純利益
現金流量
EPS
Vor Biopharma Inc (VOR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
27.42 |
124,311 |
3,408,230 |
1,055,749 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 30 '25 |
Sale |
25.12 |
24,579 |
617,424 |
779,652 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 27 '25 |
Sale |
28.12 |
90,941 |
2,557,261 |
1,180,060 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 23 '25 |
Sale |
28.01 |
76,880 |
2,153,409 |
1,324,346 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 24 '25 |
Sale |
28.01 |
53,345 |
1,494,193 |
1,271,001 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 20 '25 |
Sale |
29.67 |
92,023 |
2,730,483 |
0 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 21 '25 |
Sale |
28.11 |
25,027 |
703,509 |
1,401,226 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 17 '25 |
Sale |
30.25 |
25,717 |
777,987 |
1,178,725 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 20 '25 |
Sale |
30.05 |
11,616 |
349,101 |
1,167,109 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 21 '25 |
Sale |
30.07 |
200 |
6,015 |
1,166,909 |
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):